1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. Histogenics Acquires ProChon Biotech

M&A Deal Summary

Histogenics Acquires ProChon Biotech

On May 1, 2011, Histogenics acquired life science company ProChon Biotech

Acquisition Highlights
  • This is Histogenics’ 1st transaction in the Life Science sector.
  • This is Histogenics’ 1st transaction in the United States.
  • This is Histogenics’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2011-05-01
Target ProChon Biotech
Sector Life Science
Buyer(s) Histogenics
Deal Type Add-on Acquisition
Advisor(s) Outcome Capital (Financial)

Target

ProChon Biotech

Woburn, Massachusetts, United States
ProChon is a privately held biotechnology company focused on modulating the fibroblast growth factor system to enable it to create more effective solutions for tissue regeneration.

Search 214,557 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Histogenics

Waltham, Massachusetts, United States
Category Company
Founded 2000
Sector Life Science
DESCRIPTION

Histogenics is a regenerative medicine company that combines cell therapy and tissue engineering technologies to develop highly innovative products for tissue repair and regeneration. Histogenics was founded in 2000 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2011 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal